Breaking News Instant updates and real-time market news.

DIA

Diamonds Fund ETF

, DIS

Disney

09:40
11/10/17
11/10
09:40
11/10/17
09:40

Unusually active option classes on open November 10th

Unusual total active option classes on open include: Diamond ETF (DIA), Disney (DIS), J C Penney (JCP), Johnson & Johnson (JNJ), and Kroger (KR).

DIA

Diamonds Fund ETF

DIS

Disney

JCP

J.C. Penney

JNJ

Johnson & Johnson

KR

Kroger

  • 10

    Nov

  • 30

    Nov

  • 14

    Dec

DIA Diamonds Fund ETF

DIS Disney

11/10/17
PIPR
11/10/17
NO CHANGE
Target $120
PIPR
Overweight
Disney price target lowered to $120 from $130 at Piper Jaffray
Piper Jaffray analyst Stan Meyers lowered his price target for Disney shares to $120 saying investments into BamTech, Hulu, lower ratings at ABC/ESPN and Hurricane Irma drove the miss in Q4. The analyst, however, remains "upbeat" on the shares citing a "strong" film slate, growth from recent and upcoming carriage renewals, and continued momentum at the Parks. Meyers keeps an Overweight rating on Disney.
11/10/17
LOOP
11/10/17
NO CHANGE
Target $104
LOOP
Hold
Disney revenue miss due to shortfall at Media Networks, says Loop Capital
Loop Capital analyst David Miller says Disney's revenue miss was largely the result of a notable shortfall at Media Networks, where sales of $5.46B were down 3.4% on the year largely because of lower advertising sales at ABC. Media's EBIT result was constrained by higher NBA rights costs, says the analyst, adding that Disney CFO has also warned that ESPN ad sales are pacing down in Q1. Miller notes that Disney's Theme Parks division is performing well, with Q4 revenues rising 6.4% thanks to higher occupancy levels at both Orlando and Anaheim along with the effects of surge pricing. The analyst keeps his Hold rating and nudges the price target to $104 from $103 following Q4 results.
11/10/17
BERN
11/10/17
NO CHANGE
Target $101
BERN
Market Perform
Disney deal for Fox wouldn't solve underlying problems, says Bernstein
Bernstein analyst Todd Juenger noted that Disney (DIS) has gone from a situation where reported EPS was going up but its stock price was going down to one where EPS is going down but the stock has been going up a bit driven by M&A speculation. However, he contends that the current round of renewed M&A speculation is happening because underlying fundamentals are "so bad" and even if a deal for Disney to buy Fox (FOXA) assets happens it wouldn't solve the underlying problems. He also thinks the chances of a Disney-Fox deal as currently described are "very low." Juenger maintains a Market Perform rating and $101 price target on Disney shares.
11/10/17
EVER
11/10/17
NO CHANGE
Target $120
EVER
Outperform
Evercore ISI incrementally optimistic on Disney's FY18 outlook
Evercore ISI analyst Vijay Jayant came away from Disney's lackluster Q4 report incrementally optimistic on the company's FY18 outlook. He said the massive film slate for the coming year should translate into double-digit full year revenue and OIBDA gains, while underlying trends at the media networks division are improving. Jayant believes management is making the right strategic decisions and the fresh guidance could be a modest postive for sentiment. Jayant rares Disney and Outperform with a $120 price target.
JCP J.C. Penney

10/30/17
SBSH
10/30/17
DOWNGRADE
Target $16
SBSH
Sell
Macy's downgraded to Sell from Neutral at Citi
Citi analyst Paul Lejuez downgraded Macy's (M) to Sell and cut his price target for the shares to $16 from $21. The retailer's sales and margins have been pressured for several years, and J.C. Penney's (JCP) weak Q3 preannouncement on Friday serves as reminder of just how challenging the department store space is, Lejuez tells investors in a research note. He believes risks are mounting at Macy's ahead of what is likely to be another promotional holiday season. Macy's has not found the right tools to offset negative store traffic and margin pressures, the analyst contends. Lejuez this morning also downgraded Penny to Sell.
10/30/17
SUSQ
10/30/17
DOWNGRADE
Target $3
SUSQ
Neutral
J.C. Penney downgraded to Neutral at Susquehanna
As reported previously, Susquehanna analyst Bill Dreher downgraded J.C. Penney to Neutral from Positive following its Q3 results. The analyst cited its continued gross margin pressures and the fact that sales driving initiatives are taking longer than expected to materialize. Dreher lowered his price target to $3 from $6.50 on J.C. Penney shares.
10/30/17
NRCS
10/30/17
DOWNGRADE
NRCS
Neutral
J.C. Penney downgraded to Neutral from Buy at Northcoast
10/30/17
10/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Motors (GM) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying his price target of $32 offers 28% potential downside. The analyst continues to believe the North America auto cycle has peaked and he remains cautious on the sector. 2. Merck (MRK) downgraded to Hold from Buy at SunTrust and to Equal Weight from Overweight at Morgan Stanley, as well as Barclays. 3. J.C. Penney (JCP) downgraded to Sell from Neutral at Citi, to Neutral from Buy at Northcoast, and to Neutral from Positive at Susquehanna. 4. Macy's (M) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez saying the retailer's sales and margins have been pressured for several years, and J.C. Penney's weak third quarter preannouncement on Friday serves as reminder of just how challenging the department store space is. 5. Under Armour (UAA, UA) downgraded to Underperform from Neutral at BofA/Merrill with analyst Robert Ohmes saying he expects management to lower fourth quarter guidance on its Q3 conference call due to the highly promotional environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JNJ Johnson & Johnson

10/18/17
COWN
10/18/17
NO CHANGE
Target $155
COWN
Outperform
Johnson & Johnson price target raised to $155 from $147 at Cowen
Cowen analyst Joshua Jennings raised his price target on Johnson & Johnson to $155 from $147 following solid Q3 results. The analyst cited the reacceleration of the Pharma group and improvements in the Medical Devices and Consumer units, which he believes will drive sustainable revenue growth. Jennings reiterated his Outperform rating on Johnson & Johnson shares.
10/18/17
ARGS
10/18/17
NO CHANGE
Target $165
ARGS
Buy
Johnson & Johnson price target raised to $165 from $145 at Argus
Argus analyst David Toung raises his price target on Johnson & Johnson to $165 and kept his Buy rating following Q3 results. Toung says the top-line growth was driven by oncology and immunology drugs, products gained through the Actelion acquisition, and improved performance in the Consumer segment. The analyst is also positive on the company's strategy of boosting growth through acquisitions and shedding of slower-growth businesses.
10/19/17
FBCO
10/19/17
NO CHANGE
Target $154
FBCO
Outperform
Johnson & Johnson price target raised to $154 from $147 at Credit Suisse
Credit Suisse analyst Vamil Divan raised his price target for Johnson & Johnson to $154 from $147 following Q3 results. The analyst reiterates an Outperform rating on the shares.
10/26/17
JANY
10/26/17
DOWNGRADE
Target $27
JANY
Sell
Pacira downgraded to Sell from Neutral at Janney Capital
Janney Capital analyst Ken Trbovich downgraded Pacira Pharmaceuticals (PCRX) to Sell and cut his price target for the shares to $27 from $36. Symphony Health data shows no signs Exparel growth is taking hold, Trbovich tells investors in a research note. The analyst sees no evidence of a benefit from Johnson & Johnson's (JNJ) Depuy Synthes sales force and believes Q3 estimates are too high. Deterioration in Exparel growth is likely to lead management to cut their full outlook when reporting Q3, Trbovich writes. He sees 20% downside from current share levels. Pacira closed yesterday down 5% to $31.85.
KR Kroger

10/12/17
PIVT
10/12/17
NO CHANGE
Target $25
PIVT
Buy
Kroger analyst day 'generally positive' for bulls, says Pivotal Research
Pivotal Research analyst Ajay Jain says that while he remains confident about Kroger's fiscal year 2017 earnings outlook, he "still can't get" to management's outlook of $2.00-$2.05, which was reaffirmed yesterday. The analyst raised his FY17 earnings per share estimate to $1.96 from $1.90 to reflect greater confidence following yesterday's analyst day. The takeaways were "generally positive" for bulls, Jain tells investors in an intraday research note. Regarding the potential sale of Kroger's convenience store business, Jain says any deal should be incremental to FY18 earnings. He keeps a Buy rating on the shares with a $25 price target.
11/03/17
DBAB
11/03/17
NO CHANGE
Target $51
DBAB
Buy
Blackhawk oversold after key contract renewal, says Deutsche Bank
Deutsche Bank analyst Bryan Keane believes the recent weakness in shares of Blackhawk Network (HAWK) provides a buying opportunity. The company yesterday announced a key contract renewal with Kroger, its largest customer, which likely represents 6% of worldwide operating revenue, Keane tells investors in a research note. The stock fell sharply after the last earnings call after the company warned of U.S. Retail pricing pressure, but pricing is now under control after this contract renewal, the analyst contends. He now believe that all the material Blackhawk contracts have been extended until 2021. Keane views the stock as oversold at current levels and keeps a Buy rating on the name with a $51 price target.
11/06/17
NRCS
11/06/17
UPGRADE
NRCS
Buy
Kroger upgraded to Buy from Neutral at Northcoast
11/06/17
11/06/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Neutral from Sell at Citi with analyst Mark May saying he views the current valuation as fair, noting the shares have underperformed peers year-to-date despite rallying 41% from the post-second quarter earnings report lows. 2. Cree (CREE) upgraded to Buy from Hold at Deutsche Bank with analyst Vishal Shah saying the company's Wolfspeed business opportunity remains underappreciated even after the rally attributed to the CEO transition announcement. 3. Hyatt (H) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jeffrey Donnelly saying the company's shift to a fee-driven model should lead to a higher multiple. 4. Kroger (KR) upgraded to Buy from Neutral at Northcoast. 5. Dentsply Sirona (XRAY) upgraded to Outperform from Market Perform at Barrington. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

OSUR

OraSure

$16.55

2.59 (18.55%)

07:36
11/22/17
11/22
07:36
11/22/17
07:36
Recommendations
OraSure analyst commentary  »

OraSure contract win…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$16.73

0.29 (1.76%)

07:35
11/22/17
11/22
07:35
11/22/17
07:35
Technical Analysis
Technical View: GameStop trades higher after earnings and outlook »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$14.67

0.15 (1.03%)

07:35
11/22/17
11/22
07:35
11/22/17
07:35
Recommendations
Nuance analyst commentary  »

In-line guidance likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AAPL

Apple

$173.14

3.16 (1.86%)

, BAC

Bank of America

$26.73

-0.01 (-0.04%)

07:35
11/22/17
11/22
07:35
11/22/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AAPL

Apple

$173.14

3.16 (1.86%)

BAC

Bank of America

$26.73

-0.01 (-0.04%)

MU

Micron

$49.40

1.76 (3.69%)

T

AT&T

$34.33

-0.31 (-0.89%)

ORCL

Oracle

$48.63

-0.39 (-0.80%)

AKS

AK Steel

$4.85

0.22 (4.75%)

PG

Procter & Gamble

$88.72

0.45 (0.51%)

TRIP

TripAdvisor

$32.81

2.33 (7.64%)

PEP

PepsiCo

$116.05

1.14 (0.99%)

PAGP

Plains GP Holdings

$20.48

-0.41 (-1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

  • 19

    Dec

EKSO

Ekso Bionics

$4.13

1.21 (41.44%)

07:33
11/22/17
11/22
07:33
11/22/17
07:33
Technical Analysis
Technical View: Ekso Bionics trades sharply higher, edging 52-week high »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$30.20

0.5 (1.68%)

07:32
11/22/17
11/22
07:32
11/22/17
07:32
Initiation
Nutanix initiated  »

Nutanix initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 07

    Dec

  • 12

    Dec

HPE

HP Enterprise

$14.12

0.03 (0.21%)

07:32
11/22/17
11/22
07:32
11/22/17
07:32
Recommendations
HP Enterprise analyst commentary  »

HP Enterprise CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 11

    Dec

GE

General Electric

$17.83

-0.15 (-0.83%)

, DKS

Dick's Sporting

$28.58

-0.52 (-1.79%)

07:30
11/22/17
11/22
07:30
11/22/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GE

General Electric

$17.83

-0.15 (-0.83%)

DKS

Dick's Sporting

$28.58

-0.52 (-1.79%)

ROST

Ross Stores

$72.67

-0.07 (-0.10%)

ILG

ILG

$28.11

-0.5 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

  • 01

    Dec

  • 12

    Dec

DLTR

Dollar Tree

$99.46

2.35 (2.42%)

07:29
11/22/17
11/22
07:29
11/22/17
07:29
Recommendations
Dollar Tree analyst commentary  »

Dollar Tree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:28
11/22/17
11/22
07:28
11/22/17
07:28
General news
Futures above fair value ahead of holiday »

Stock futures are…

SHOO

Steven Madden

$39.80

-0.6 (-1.49%)

07:28
11/22/17
11/22
07:28
11/22/17
07:28
Conference/Events
Steven Madden management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

BURL

Burlington Stores

$104.94

-1.61 (-1.51%)

07:25
11/22/17
11/22
07:25
11/22/17
07:25
Recommendations
Burlington Stores analyst commentary  »

Burlington Stores price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLH

Red Lion Hotels

$8.55

0.1 (1.18%)

07:24
11/22/17
11/22
07:24
11/22/17
07:24
Conference/Events
Red Lion Hotels management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 06

    Dec

TIVO

TiVo

$17.65

0.15 (0.86%)

, CMCSA

Comcast

$36.42

0.59 (1.65%)

07:24
11/22/17
11/22
07:24
11/22/17
07:24
Recommendations
TiVo, Comcast, Comcast analyst commentary  »

TiVo ITC win raises odds…

TIVO

TiVo

$17.65

0.15 (0.86%)

CMCSA

Comcast

$36.42

0.59 (1.65%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$184.15

1.81 (0.99%)

07:22
11/22/17
11/22
07:22
11/22/17
07:22
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTI

Pluristem

$1.51

0.05 (3.42%)

07:20
11/22/17
11/22
07:20
11/22/17
07:20
Conference/Events
Pluristem management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

HRL

Hormel Foods

$34.52

1.12 (3.35%)

07:20
11/22/17
11/22
07:20
11/22/17
07:20
Recommendations
Hormel Foods analyst commentary  »

Hormel Foods 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

07:20
11/22/17
11/22
07:20
11/22/17
07:20
General news
FX Update: The dollar has traded softer »

FX Update: The dollar has…

BAX

Baxter

$64.25

0.37 (0.58%)

07:19
11/22/17
11/22
07:19
11/22/17
07:19
Recommendations
Baxter analyst commentary  »

Baxter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 14

    Dec

GME

GameStop

$16.73

0.29 (1.76%)

07:19
11/22/17
11/22
07:19
11/22/17
07:19
Recommendations
GameStop analyst commentary  »

GameStop price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTA

Prothena

$45.97

1.37 (3.07%)

07:19
11/22/17
11/22
07:19
11/22/17
07:19
Conference/Events
Prothena management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

CRM

Salesforce

$108.80

1.43 (1.33%)

07:18
11/22/17
11/22
07:18
11/22/17
07:18
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

QADA

QAD Inc.

$39.95

1.75 (4.58%)

07:15
11/22/17
11/22
07:15
11/22/17
07:15
Recommendations
QAD Inc. analyst commentary  »

QAD Inc. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$12.85

-0.59 (-4.39%)

, UA

Under Armour

$11.36

-0.71 (-5.88%)

07:13
11/22/17
11/22
07:13
11/22/17
07:13
Recommendations
Under Armour, Under Armour analyst commentary  »

Under Armour continued…

UAA

Under Armour

$12.85

-0.59 (-4.39%)

UA

Under Armour

$11.36

-0.71 (-5.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRTS

Roadrunner

$8.15

0.16 (2.00%)

07:10
11/22/17
11/22
07:10
11/22/17
07:10
Hot Stocks
Roadrunner appoints James Staley as chairman of the board »

Roadrunner Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.